Literature DB >> 26555486

Psychiatric disorders in patients with multiple sclerosis.

Ana Claudia de Cerqueira1, Patricia Semionato de Andrade2, Jose Maurício Godoy Barreiros2, Antonio Lúcio Teixeira3, Antonio Egídio Nardi4.   

Abstract

UNLABELLED: The aim of this study was to evaluate the frequency of psychiatric disorders, particularly mood disorders and anxiety in an outpatient sample of patients with multiple sclerosis in Brazil, and correlate the result with sociodemographic and clinical data.
METHODS: Cross-sectional study, patients evaluated consecutively, for the clinical, demographic, prevalence of psychiatric disorders was used structured interview (MINI), severity of symptoms of depression and anxiety was used Beck inventory.
RESULTS: The prevalence of major lifelong depression in this population was 36.6%, and the risk of suicide was high. There was no detectable correlation between depression, degree of disability, or disease duration.
CONCLUSION: The prevalence of mood disorders is high in MS. Depression is an important factor related to the risk of suicide and should be investigated systematically.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26555486     DOI: 10.1016/j.comppsych.2015.08.001

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  6 in total

1.  Neuromyelitis optica: suicide risk and psychiatric comorbidities.

Authors:  Andres María Villa; Victoria Carla Fernández
Journal:  J Neurol       Date:  2018-06-08       Impact factor: 4.849

2.  Behavioral Symptoms in Pediatric Multiple Sclerosis: Relation to Fatigue and Cognitive Impairment.

Authors:  Leigh Charvet; Bianca Cersosimo; Colleen Schwarz; Anita Belman; Lauren B Krupp
Journal:  J Child Neurol       Date:  2016-03-09       Impact factor: 1.987

3.  Mental toughness, sleep disturbances, and physical activity in patients with multiple sclerosis compared to healthy adolescents and young adults.

Authors:  Dena Sadeghi Bahmani; Markus Gerber; Nadeem Kalak; Sakari Lemola; Peter J Clough; Pasquale Calabrese; Vahid Shaygannejad; Uwe Pühse; Edith Holsboer-Trachsler; Serge Brand
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-27       Impact factor: 2.570

Review 4.  Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches.

Authors:  Rashad Hussain; Hira Zubair; Sarah Pursell; Muhammad Shahab
Journal:  Brain Sci       Date:  2018-09-15

5.  Neuropsychiatric assessments in patients with multiple sclerosis in early phases and with low disability.

Authors:  Sergio L Schmidt; Michele Santos da Silva; Juliana J Schmidt; Ana Lucia Novais Carvalho; Claudia Cristina Ferreira Vasconcelos; Renata Alves Paes; Yolanda Em Boechat; Rafael Neder; Regina P Alvarenga
Journal:  Neuropsychiatr Dis Treat       Date:  2018-06-22       Impact factor: 2.570

Review 6.  A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications.

Authors:  Larissa Hauer; Julian Perneczky; Johann Sellner
Journal:  J Neurol       Date:  2020-07-27       Impact factor: 4.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.